Extreme Networks

Extreme Networks (NASDAQ:EXTR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 0 1 0 0 Last 30D 1 0 0 0 0 1M Ago 4 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Extreme Networks, presenting an average target of $15.33, a high estimate of $17.00, and a low estimate of $13.00. This current average has increased by 4.5% from the previous average price target of $14.67. Breaking Down Analyst Ratings: A Detailed Examination An in-depth analysis of recent analyst actions unveils how financial experts perceive Extreme Networks. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Alex Henderson Needham Maintains Buy $16.50 - Dave Kang B. Riley Securities Raises Buy $15.00 $14.00 Christian Schwab Craig-Hallum Lowers Hold $13.00 $15.00 Mike Genovese Rosenblatt Raises Buy $17.00 $15.00 Alex Henderson Needham Maintains Buy $16.50 - Dave Kang B. Riley Securities Maintains Buy $14.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Extreme Networks. This information provides a snapshot ...Full story available on Benzinga.com

Related tickers: EXTR.

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms. Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Soligenix, Inc. (NASDAQ: SNGX) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA. Longeveron Inc. (NASDAQ: LGVN) surged 54% to $2.6350 following insider buys from multiple company executives. SuperCom Ltd. (NASDAQ: SPCB) shares gained 39.4% to $0.3849 after jumping around 18% on Friday. Piedmont Lithium Inc. (NYSE: PLL) shares gained 32.1% to $16.75 following a 5% decline on Friday. Snap One Holdings Corp. (NASDAQ: SNPO) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies. Organovo Holdings, Inc. (NASDAQ: ONVO) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo. Kuke Music Holding Limited (NASDAQ: KUKE) jumped 27% to $2.7650. HUB Cyber Security Ltd. (NASDAQ: HUBC) gained 24% to $1.61 after gaining over 11% on Friday. Edgio, Inc. (NASDAQ: EGIO) gained 24% to $22.18. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ...

Related tickers: YSG, DXYZ, ONVO, KUKE, QTTB, IMCC, LGVN, NVX, SPCB, CMAX, CENX, RARE, SNPO, EXTR, MRNS, LOCL, INFA, AEYE, NXPL, RENT, TCON, HUBC, WIRE, SES, BTCY, SWVL, CYN, PMN, EGIO, DM, BHVN, PSNY, MPW, VERU, PROK, PLL, ADIL, SRFM, OCX, ATHE, NMRA, BB, KAVL, COCH, SPWR, VIAO, MNDR, SNGX.